Tech Company Financing Transactions

PharmaCord Funding Round

Permira participated in a venture round for PharmaCord. The financing round was announced by the company on 6/7/2024.

Transaction Overview

Company Name
Announced On
6/7/2024
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to expand operations and its business reach. Founder and Chief Executive Officer Nitin Sahney and the management team will continue to lead PharmaCord and will remain significant investors in the company alongside the Permira funds.

Company Information

Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
150 Hilton Drive
Jeffersonville, IN 47130
USA
Email Address
Overview
PharmaCord works on behalf of pharmaceutical manufacturers to overcome barriers and help patients receive and remain on therapy. Patients won't know our names, but they'll know yours. As access to specialty prescriptions increases, so will trust in your medication brand. We are highly motivated and passionate about providing the highest quality customer support to our patients.
Profile
PharmaCord LinkedIn Company Profile
Social Media
PharmaCord Company Twitter Account
Company News
PharmaCord News
Facebook
PharmaCord on Facebook
YouTube
PharmaCord on YouTube

Management Team

Title
Name
Email & Social
Chairman
Jim Karp
  Jim Karp LinkedIn Profile  Jim Karp Twitter Account  Jim Karp News  Jim Karp on Facebook
Chief Executive Officer
Nitin Sahney
  Nitin Sahney LinkedIn Profile  Nitin Sahney Twitter Account  Nitin Sahney News  Nitin Sahney on Facebook
Chief Financial Officer
Patrick Lee
  Patrick Lee LinkedIn Profile  Patrick Lee Twitter Account  Patrick Lee News  Patrick Lee on Facebook
Chief Information Officer
Phani Konduru
  Phani Konduru LinkedIn Profile  Phani Konduru Twitter Account  Phani Konduru News  Phani Konduru on Facebook
Chief Information Officer
Aaron Seamans
  Aaron Seamans LinkedIn Profile  Aaron Seamans Twitter Account  Aaron Seamans News  Aaron Seamans on Facebook
Controller
Dean Dimitropoulos
  Dean Dimitropoulos LinkedIn Profile  Dean Dimitropoulos Twitter Account  Dean Dimitropoulos News  Dean Dimitropoulos on Facebook
Executive Vice President
David Hileman
  David Hileman LinkedIn Profile  David Hileman Twitter Account  David Hileman News  David Hileman on Facebook
Vice President
Kari Glenn
  Kari Glenn LinkedIn Profile  Kari Glenn Twitter Account  Kari Glenn News  Kari Glenn on Facebook
Vice President
Kellen Rollins
  Kellen Rollins LinkedIn Profile  Kellen Rollins Twitter Account  Kellen Rollins News  Kellen Rollins on Facebook
Vice President
Denise Von Dohren
  Denise Von Dohren LinkedIn Profile  Denise Von Dohren Twitter Account  Denise Von Dohren News  Denise Von Dohren on Facebook
Vice President
Sarah Walker
  Sarah Walker LinkedIn Profile  Sarah Walker Twitter Account  Sarah Walker News  Sarah Walker on Facebook
VP - Administration
Beth Roberts
  Beth Roberts LinkedIn Profile  Beth Roberts Twitter Account  Beth Roberts News  Beth Roberts on Facebook
VP - Client Services
Cindy Padgett
  Cindy Padgett LinkedIn Profile  Cindy Padgett Twitter Account  Cindy Padgett News  Cindy Padgett on Facebook
VP - General Counsel
Rob Brown
  Rob Brown LinkedIn Profile  Rob Brown Twitter Account  Rob Brown News  Rob Brown on Facebook


 

 

Browse more venture capital transactions:

Prev: 6/7/2024: Kaspar& venture capital transaction
Next: 6/7/2024: Continuity venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on funding rounds that are announced publicly. VC investment data records on this site come from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary